Effect of Microplastics on Nasal and Intestinal Microbiota of High-Exposure Population: Protocol for an Observational Cross-sectional Study — Xiyu Zhang (2022) | RDL Network
Effect of Microplastics on Nasal and Intestinal Microbiota of High-Exposure Population: Protocol for an Observational Cross-sectional Study
Preprint 2022 en
Authors
XZ
Xiyu Zhang
YH
Yuchi He
ZX
Ziyan Xie
Abstract
1 min read
Abstract Background: Microplastics have the characteristics of small size, high specific area, strong ability to adsorb pollutants, and difficult to degrade. They have become a major global environmental problem that humans urgently need to address. A balanced micro-ecosystem is essential to human health. Animal studies have shown that long-term exposure to microplastics can change the characteristics of the microbiota in organisms, leading to respiratory, digestive, immune and other system diseases. However, the current research on microplastics is still dominated by animal experiments, and the impact of microplastics on human health is still in its infancy, so relevant research is urgently needed. Methods/Design: Sixty participants with high exposure to microplastics will come from a plastic factory in Chengdu, China. We will conduct 16S rRNA sequencing and 8700 LDIR laser infrared imaging to the samples from the participants and from the environment. We will evaluate the health status of the participants through Short-Form Health Survey 36 (SF-36). For comparison, we will also collect samples and questionnaires from 60 volunteers from an area with good environmental quality in Chengdu. To find out the potential predictors and to access the difference between the groups, statistical analysis will be performed in the end. Discussion: The study will be the first observational cross-sectional study focusing on the effects of microplastics on nasal and intestinal microbiota of high-exposure population. The study is expected to provide reliable evidence to fill the gaps in the impact of microplastics on human health. Trial registration: This trial was registered with Chinese Clinical Trial Registry (ChiCTR2100049480) on August 2, 2021.
Olivier Brandts‐Longtin, Manoj M. Lalu, Euan Adie, Marc A. Albert, Elham Almoli, Faris Almoli, Gregory L. Bryson, Christophe Dony, Daniel J. Dunleavy, Agnes Grudniewicz, Christine Lehmann, Rémy Lhoest, David Moher, Joshua Montroy, Mallory S. Pitts, Alicia Ricketts, Paul Thirion, Kelly D. Cobey
Marta M. Jankowska, Dorothy D. Sears, Loki Natarajan, Elena Martínez, Cheryl A.M. Anderson, James Sallis, Stephen A. Matthews, Katie Crist, Lindsay Dillon, Eileen Johnson, Angelica Barrera-Ng, Kelsey Full, Suneeta Godbole, Jacqueline Kerr
Discussion(0)
No comments yet. Be the first to comment.